Skip Navigation


Brain Advance Access originally published online on May 9, 2006
Brain 2006 129(7):1748-1757; doi:10.1093/brain/awl103
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/7/1748    most recent
awl103v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alonso-Frech, F.
Right arrow Articles by Obeso, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alonso-Frech, F.
Right arrow Articles by Obeso, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease

F. Alonso-Frech1, I. Zamarbide2, M. Alegre, M. C. Rodríguez-Oroz, J. Guridi, M. Manrique, M. Valencia, J. Artieda and J. A. Obeso

Department of Neurology and Neurosurgery, Neuroscience Area, Clinica Universitaria and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra Pamplona, Spain 1 Present addresses: Section of Neurology, Hospital de Fuenlabrada Madrid, Spain 2 Section of Neurology, Hospital Universitario de Guadalajara Guadalajara, Spain

Correspondence to: José A. Obeso, Department of Neurology and Neurosurgery, Clinica Universitaria, Avenida de Pio XII 36, Pamplona 31008, Spain E-mail: jobeso{at}unav.es

The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson's disease is not well understood. We have recorded local field potentials (LFP) from macroelectrodes implanted in the subthalamic nucleus (STN) of 14 patients with Parkinson's disease following surgical treatment with deep brain stimulation. Patients were studied in the ‘Off’ medication state and in the ‘On’ motor state after administration of levodopa–carbidopa (po) or apomorphine (sc) that elicited dyskinesias in 11 patients. The logarithm of the power spectrum of the LFP in selected frequency bands (4–10, 11–30 and 60–80 Hz) was compared between the ‘Off’ and ‘On’ medication states. A peak in the 11–30 Hz band was recorded in the ‘Off’ medication state and reduced by 45.2% (P < 0.001) in the ‘On’ state. The ‘On’ was also associated with an increment of 77. 6% (P < 0.001) in the 4–10 Hz band in all patients who showed dyskinesias and of 17.8% (P < 0.001) in the 60–80 Hz band in the majority of patients. When dyskinesias were only present in one limb (n = 2), the 4–10 Hz peak was only recorded in the contralateral STN. These findings suggest that the 4–10 Hz oscillation is associated with the expression of LID in Parkinson's disease.

Key Words: dyskinesias; subthalamic nucleus; oscillatory activity; Parkinson's disease

Abbreviations: DA, dopamine; DBS, deep brain stimulation; DID, dyskinesia–improvement–dyskinesia; GPi, globus pallidus pars interna; FFT, fast Fourier transformation; LID, levodopa-induced dyskinesias; LFP, local field potentials; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; STN, subthalamic nucleus

Received October 12, 2005. Revised December 24, 2005. Accepted March 28, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. Schuster, A. Nadjar, J. T. Guo, Q. Li, C. Ittrich, B. Hengerer, and E. Bezard
The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease
J. Neurosci., April 23, 2008; 28(17): 4311 - 4316.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Lalo, S. Thobois, A. Sharott, G. Polo, P. Mertens, A. Pogosyan, and P. Brown
Patterns of Bidirectional Communication between Cortex and Basal Ganglia during Movement in Patients with Parkinson Disease
J. Neurosci., March 19, 2008; 28(12): 3008 - 3016.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. G. Androulidakis, A. A. Kuhn, C. Chu Chen, P. Blomstedt, F. Kempf, A. Kupsch, G.-H. Schneider, L. Doyle, P. Dowsey-Limousin, M. I. Hariz, et al.
Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease
Brain, February 1, 2007; 130(2): 457 - 468.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Weinberger, N. Mahant, W. D. Hutchison, A. M. Lozano, E. Moro, M. Hodaie, A. E. Lang, and J. O. Dostrovsky
Beta Oscillatory Activity in the Subthalamic Nucleus and Its Relation to Dopaminergic Response in Parkinson's Disease
J Neurophysiol, December 1, 2006; 96(6): 3248 - 3256.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.